With treatment, the five-year survival rate is >80% and fewer than 30% of affected individuals require long-term dialysis. A study performed in Australia and New Zealand demonstrated that in patients requiring renal replacement therapy (including dialysis) the median survival time is 5.93 years. Without treatment, virtually every affected person will die from either advanced kidney failure or lung hemorrhages.
Goodpasture syndrome
Nephrogenic systemic fibrosis
CHILD syndrome
Hopkins syndrome
CREST syndrome
MOMO syndrome
OSLAM syndrome
Pitt–Hopkins syndrome